Trinity Biotech plc (TRIB)

NASDAQ: TRIB · IEX Real-Time Price · USD
0.430
+0.055 (14.59%)
At close: Nov 28, 2023, 4:00 PM
0.390
-0.040 (-9.37%)
Pre-market: Nov 29, 2023, 8:17 AM EST
14.59%
Market Cap 16.44M
Revenue (ttm) 66.27M
Net Income (ttm) -30.82M
Shares Out 38.21M
EPS (ttm) -1.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 293,569
Open 0.380
Previous Close 0.376
Day's Range 0.380 - 0.560
52-Week Range 0.370 - 1.370
Beta 1.45
Analysts n/a
Price Target n/a
Earnings Date Dec 14, 2023

About TRIB

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, ru... [Read more]

Sector Healthcare
Founded 1992
Employees 398
Stock Exchange NASDAQ
Ticker Symbol TRIB
Full Company Profile

Financial Performance

Financial Statements

News

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical l...

17 hours ago - GlobeNewsWire

Trinity Biotech Announces Q2 2023 Financial Results

DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

2 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will r...

2 months ago - GlobeNewsWire

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

DUBLIN, Ireland, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical ...

2 months ago - GlobeNewsWire

Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System

DUBLIN, Ireland, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Premier Resolution System, an automated analyzer for th...

4 months ago - GlobeNewsWire

Trinity Biotech Announces Q1 2023 Financial Results

DUBLIN, Ireland, July 06, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

5 months ago - GlobeNewsWire

Trinity Biotech plc to Announce First Quarter Fiscal Year 2023 Financial Results

DUBLIN, July 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will re...

5 months ago - GlobeNewsWire

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

DUBLIN, Ireland, May 05, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical la...

7 months ago - GlobeNewsWire

Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to Biosynth

DUBLIN, Ireland, April 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical ...

7 months ago - GlobeNewsWire

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

DUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical ...

7 months ago - GlobeNewsWire

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

DUBLIN, Ireland, March 23, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory market...

8 months ago - GlobeNewsWire

Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing Algorithm

DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical l...

8 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results

Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN Conference Call Scheduled for March 23, 2023 at 10:00 am EASTERN

9 months ago - GlobeNewsWire

Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions

DUBLIN, Ireland, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical la...

10 months ago - GlobeNewsWire

Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry

DUBLIN, Ireland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, t...

11 months ago - GlobeNewsWire

Trinity Biotech Announces Q3 2022 Financial Results

DUBLIN, Ireland, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN

1 year ago - GlobeNewsWire

Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference

DUBLIN, Ireland, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, is...

1 year ago - GlobeNewsWire

Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance

DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN Conference Call Scheduled for November 3, 2022 at 11:00 am EASTERN

1 year ago - GlobeNewsWire

Trinity Biotech Announces the Appointment of Tom Lindsay to its Board of Directors

DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO

DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech Announces Results of AGM

DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory market...

1 year ago - GlobeNewsWire

Trinity Biotech Announces Quarter 1 2022 Financial Results

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

1 year ago - GlobeNewsWire

Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN

1 year ago - GlobeNewsWire